WVE Q3'26 Earnings: EPS estimate is (0.33) USD

What happened

Wave Life Sciences is set to announce its Q3'26 results on October 27 before the market opens at 7:30 AM ET. The revenue estimate is 4.51 million USD and the EPS estimate is (0.33) USD.

Confirmed

Global impact / market context

An EPS estimate of (0.33) USD means analysts expect a loss per share, so investors will compare actual results with these estimates to judge whether losses are narrowing and revenue is holding up.

Analyst inference

The table shows reported revenue swinging widely across recent quarters and revenue beating or missing estimates by large percentages, which means actual results can differ sharply from forecasts.

Analyst inference

What to watch

1. Watch whether reported Q3'26 revenue matches the 4.51 million USD estimate and whether EPS matches the (0.33) USD estimate when results are released on October 27. Confirmed
2. Compare the new revenue and EPS figures with the prior quarter's reported revenue and loss per share to see whether the company's sales and losses are stable. Proposed
3. A large revenue surprise, like the plus 352.57% beat reported earlier, would change how investors view the company's cash available and its ability to fund research spending. Analyst inference

Evidence

• Original source link unavailable